WASHINGTON, D. C. (May 14, 2001) – More than 200 meetings with Capitol Hill legislators are scheduled for biotechnology industry representatives during the Biotechnology Industry Organization’s (BIO) annual Legislative Day, May 15-16.
This annual event provides industry representatives, including CEOs and research scientists, with the opportunity to discuss policy with federal lawmakers, and to update them on the latest advances in biotechnology. Issues likely to be addressed include: Medicare reform, prescription drug pricing, food and agriculture, and R & D tax credits.
“Record-breaking attendance by the more than 150 industry representatives is a clear demonstration of our commitment to biotechnology policy at the grassroots level,” said Carl B. Feldbaum, president of BIO. “We are pleased to have so many biotechnology leaders here to discuss legislative issues and to honor the representatives who have helped so much already,” said Feldbaum.
Recipients of BIO’s Legislator of the Year awards are: Sen. Susan Collins (R-ME), Sen. Tim Hutchinson (R-AR), Sen. Edward M. Kennedy (D-MA), Rep. Benjamin L. Cardin (R-MD), Rep. Eva Clayton (D-NC), Rep. Jennifer Dunn (R-WA), Rep. Robert Ehrlich, Jr. (R-MD), Rep. Robert T. Matsui (D-CA). For information about awards ceremonies, please contact Peper Long at (202) 962-9200 or email@example.com.
BIO represents more than 950 biotechnology companies, academicinstitutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health care, agricultural, industrial and environmental biotechnology products.
# # #